View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
October 3, 2016

Edwards Lifesciences obtains CE Mark for Acumen Hypotension Probability Indicator

US-based Edwards Lifesciences has received CE Mark approval for its Acumen Hypotension Probability Indicator (HPI), which is developed to alert clinicians to potential hypotension, or abnormally low-blood pressure while a patient undergoes surgical and critical care.

US-based Edwards Lifesciences has received CE Mark approval for its Acumen Hypotension Probability Indicator (HPI), which is developed to alert clinicians to potential hypotension, or abnormally low-blood pressure while a patient undergoes surgical and critical care.

Compatible on Edwards' minimally invasive and hemodynamic monitoring solutions, the HPI is comprised of a hypotension probability parameter which is instrumental in indicating hypotensive occurrences using machine learning techniques developed from more than 20,000 past patient events.

An alarm, fitted into the system, warns clinicians when hypotension probability exceeds the limit and a secondary screen visually connects blood pressure to hemodynamic flow parameters, such as cardiac output and contractility.

"An alarm, fitted into the system, warns clinicians when hypotension probability exceeds the limit."

HPI is part of Edwards Acumen decision-support software suite and is run by the minimally invasive FloTrac IQ sensor, within the IQ family of hemodynamic solutions.

Edwards corporate critical care vice-president Catherine Szyman said: "European commercial release of the Acumen Hypotension Probability Indicator builds on a strong foundation of innovation and provides clinicians with the insights to help them make decisions earlier.”

The company is planning to commercially launch HPI in Europe this year and a worldwide launch slated next year.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU